Chargement en cours...
Intracellular targeting with engineered proteins
If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated...
Enregistré dans:
| Publié dans: | F1000Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
F1000Research
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984483/ https://ncbi.nlm.nih.gov/pubmed/27547383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8915.1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|